Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are male, aged 18 or older, and have been diagnosed with prostate cancer (a specific type called adenocarcinoma).
- People whose prostate cancer has spread to other parts of the body and is getting worse, shown by two rising PSA blood test results in a row, or by changes seen on a bone scan or other imaging.
- People whose cancer shows a significant level of a protein marker called PSMA on a special scan, meaning at least one affected area lights up more brightly than the liver on that scan.
- People who are able to begin treatment within four weeks of having their PSMA PET/CT scan (a type of full-body imaging test).
- People who are willing and able to follow all of the study's requirements throughout the trial.
Who may not be able to join:
- No exclusion criteria were listed in the provided information (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 02.54137.81
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient-based response defined as a decline of serum PSA ≥50% at 12th weeks (after 2 cycles) after treatment initiation.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.